Mackay Shields LLC’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-181,555
| Closed | -$10.8M | – | 430 |
|
|
2022
Q1 | $10.8M | Sell |
181,555
-7,090
| -4% | -$421K | 0.09% | 212 |
|
|
2021
Q4 | $13.7M | Sell |
188,645
-4,443
| -2% | -$323K | 0.11% | 194 |
|
|
2021
Q3 | $13.5M | Sell |
193,088
-5,401
| -3% | -$377K | 0.13% | 180 |
|
|
2021
Q2 | $13.7M | Sell |
198,489
-110,524
| -36% | -$7.61M | 0.13% | 178 |
|
|
2021
Q1 | $20M | Sell |
309,013
-90,571
| -23% | -$5.85M | 0.15% | 145 |
|
|
2020
Q4 | $23.3M | Buy |
399,584
+29,220
| +8% | +$1.7M | 0.16% | 142 |
|
|
2020
Q3 | $23.4M | Sell |
370,364
-58,894
| -14% | -$3.72M | 0.16% | 137 |
|
|
2020
Q2 | $33M | Buy |
429,258
+108,033
| +34% | +$8.31M | 0.26% | 74 |
|
|
2020
Q1 | $24M | Sell |
321,225
-239,325
| -43% | -$17.9M | 0.22% | 105 |
|
|
2019
Q4 | $36.4M | Sell |
560,550
-888
| -0.2% | -$57.7K | 0.25% | 92 |
|
|
2019
Q3 | $35.6M | Sell |
561,438
-7,446
| -1% | -$472K | 0.22% | 108 |
|
|
2019
Q2 | $38.4M | Sell |
568,884
-113,015
| -17% | -$7.64M | 0.26% | 82 |
|
|
2019
Q1 | $44.3M | Buy |
681,899
+32,248
| +5% | +$2.1M | 0.32% | 61 |
|
|
2018
Q4 | $40.6M | Sell |
649,651
-203,393
| -24% | -$12.7M | 0.33% | 55 |
|
|
2018
Q3 | $65.9M | Buy |
853,044
+113,752
| +15% | +$8.78M | 0.5% | 26 |
|
|
2018
Q2 | $52.4M | Buy |
739,292
+10,336
| +1% | +$732K | 0.36% | 46 |
|
|
2018
Q1 | $55M | Buy |
+728,956
| New | +$55M | 0.34% | 49 |
|